Resources

  Obstructive sleep apnea (OSA) is common in people with type 2 diabetes.…

By themselves, insulin-based treatments do not adequately control glycemic variations (or excursions) in type 1 diabetes in a consistent fashion.…

Age-related hearing loss is more common in people with diabetes than those who don’t have it.…

Women with type 1 diabetes are at four times greater risk for CVD than those who don’t have diabetes, and pre-menopausal women with diabetes do not seem to have the beneficial effects on heart disease risk factors that other pre-menopausal women do….

Non-alcoholic fatty liver disease (NAFLD) has been linked to an increased risk of developing cardiovascular disease.…

Can continuous glucose monitoring (CGM) be used on infants and toddlers? Should it be?…

This study (299-OR) explored ways to modify the Diabetes Prevention Program (DPP) lifestyle change program to make it culturally and age appropriate for Native American youth.…

This retrospective study looking at data from an electronic health record database found that older patients with type 2 diabetes who started treatment with sulfonylurea (SU) drugs were significantly more likely to experience CVD than those who started with metformin….

Thanks to the great number of you who participated. As we put together the original survey our first thoughts were to find out what you wanted to know about GLP-1 analogs and what your impressions of the class of drugs are…. We asked you “what were the most important things …

One of the leading diabetes researchers in the world, Dr. Aaron I. Vinik leads the EVMS Strelitz Diabetes Center’s quest to cure diabetes. Internationally renowned for his research in the areas of hormone secreting tumors and the chronic complications of diabetes, Dr. Vinik has presented his work all over the world…. …